$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Effect of Pamidronate in Preventing Local Bone Loss After Total Hip Arthroplasty: A Randomized, Double-Blind, Controlled Trial 원문보기

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, v.16 no.3, 2001년, pp.556 - 564  

Wilkinson, J. Mark (Bone Metabolism Group, Division of Clinical Sciences (NGHT), University of Sheffield, Sheffield, United Kingdom) ,  Stockley, Ian (Lower Limb Arthroplasty Unit, Department of Orthopedics, Northern General Hospital, Sheffield, United Kingdom) ,  Peel, Nicola F. A. (Bone Metabolism Group, Division of Clinical Sciences (NGHT), University of Sheffield, Sheffield, United Kingdom) ,  Hamer, Andrew J. (Lower Limb Arthroplasty Unit, Department of Orthopedics, Northern General Hospital, Sheffield, United Kingdom) ,  Elson, Reginald A. (Lower Limb Arthroplasty Unit, Department of Orthopedics, Northern General Hospital, Sheffield, United Kingdom) ,  Barrington, N. Anne (Department of Diagnostic Imaging, Northern General Hospital, Sheffield, United Kingdom) ,  Eastell, Richard (Bone Metabolism Group, Division of Clinical Sciences (NGHT), University of Sheffield, Sheffield, United Kingdom)

Abstract AI-Helper 아이콘AI-Helper

AbstractAcute periprosthetic bone loss occurs after total hip arthroplasty. Bone loss undermines the support of the implant and may contribute to prosthetic failure. At present, there is no established prophylaxis for this process. We studied the effect of a single-dose infusion of 90 mg of pamidron...

참고문헌 (35)

  1. Acta Orthop Scand Malchau 64 497 1993 10.3109/17453679308993679 Prognosis of total hip replacement in Sweden. Follow up of 92,675 operations performed 1978-1990 

  2. Instr Course Lect Lewallen 47 243 1998 Periprosthetic fracture of the femur after total hip arthroplasty: Treatment and results to date 

  3. Instr Course Lect Gross 48 57 1999 Revision arthroplasty of the acetabulum in association with loss of bone stock 

  4. Orthop Clin North Am Duncan 29 297 1998 10.1016/S0030-5898(05)70327-8 Impaction allografting with cement for the management of femoral bone loss 

  5. Clin Orthop Bobyn 274 79 1992 10.1097/00003086-199201000-00010 Producing and avoiding stress shielding. Laboratory and clinical observations of noncemented total hip arthroplasty 

  6. Calcif Tissue Int Sabo 62 177 1998 10.1007/s002239900413 Periprosthetic mineralisation around cementless total hip endoprosthesis: Longitudinal study and cross sectional study on titanium threaded acetabular cup and cementless spotorno stem with DEXA 

  7. J Arthroplasty Kiratli 11 184 1996 10.1016/S0883-5403(05)80015-4 Measurement of bone mineral density by dual-energy X-ray absorptiometry in patients with the Wisconsin hip, an uncemented femoral stem 

  8. Clin Orthop Kroger 352 66 1998 Bone density at the proximal femur after total hip arthroplasty 

  9. Clin Orthop Nishii 339 121 1996 10.1097/00003086-199706000-00017 Longitudinal evaluation of time related bone remodelling after cementless total hip arthroplasty 

  10. European Instructional Course Lectures Willert 58 1999 

  11. Bone Russell 25 97 1999 10.1016/S8756-3282(99)00116-7 Bisphosphonates: From the laboratory to the clinic and back again 

  12. Lancet Frijlink 1 799 1979 10.1016/S0140-6736(79)91318-7 Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (A.P.D.) 

  13. N Engl J Med Berenson 334 488 1996 10.1056/NEJM199602223340802 Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group 

  14. Cancer Res Burckhardt 116 54 1989 Treatment of tumor-induced osteolysis by APD. Recent results 

  15. J Clin Endocrinol Metab Reid 79 1595 1994 Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis 

  16. Lancet Reid 1 143 1988 10.1016/S0140-6736(88)92721-3 Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) 

  17. Am J Med Thiebaud 85 207 1988 10.1016/S0002-9343(88)80344-9 A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone 

  18. J Clin Endocrinol Metab Landman 80 3465 1995 10.1210/jcem.80.12.8530584 Skeletal metabolism in patients with osteoporosis after discontinuation of long-term treatment with oral pamidronate 

  19. Wilkinson 2001 

  20. Clin Orthop Gruen 141 17 1979 Modes of failure of cemented stem-type femoral components. A radiographic analysis of loosening 

  21. Clin Orthop DeLee 121 20 1976 Radiological demarcation of cemented sockets in total hip replacement 

  22. J Bone Joint Surg Am Harris 51A 737 1969 10.2106/00004623-196951040-00012 Traumatic arthritis of the hip after dislocation and acetabular fractures: Treatment by mold arthroplasty. An end-result study using a new method of result evaluation 

  23. SF-36 Physical and Mental Health Summary Scales: A User's Manual Ware 1st Ed. 1994 

  24. The UK SF-36: An Analysis and Interpretation Manual Jenkinson 1st Ed. 1996 

  25. J Bone Miner Res Garnero 10 641 1995 10.1002/jbmr.5650100418 Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion 

  26. J Clin Endocrinol Metab Smith 83 3584 1998 Collagen cross-link excretion during space flight and bed rest 

  27. Osteoporos Int Uebelhart 11 59 2000 10.1007/s001980050007 Modifications of bone and connective tissue after orthostatic bedrest 

  28. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism Marcus 4th Ed. 262 1999 

  29. J Bone Miner Res Kroger 12 487 1997 10.1359/jbmr.1997.12.3.487 Periprosthetic bone loss and regional bone turnover in uncemented total hip arthroplasty: A prospective study using high resolution single photon emission tomography and dual-energy X-ray absorptiometry 

  30. Drugs Fitton 41 289 1991 10.2165/00003495-199141020-00009 Pamidronate. A review of its pharmacologic properties and therapeutic efficacy in resorptive bone disease 

  31. J Bone Joint Surg Br Ang 79 675 1997 10.1302/0301-620X.79B4.0790675 Periprosthetic bone remodelling after cementless total hip arthroplasty. A prospective comparison of two different implant designs 

  32. Orthop Trans Mochida 25 2001 Alendronate does not inhibit early bone apposition or remodelling around HA-coated implants 

  33. J Biomed Mater Res Horowitz 31 91 1996 10.1002/(SICI)1097-4636(199605)31:1<91::AID-JBM11>3.0.CO;2-P Pharmacologic inhibition of particulate-induced bone resorption 

  34. Ann Rheum Dis Sabokbar 57 614 1998 10.1136/ard.57.10.614 Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption 

  35. Clin Orthop Shanbhag 344 33 1997 10.1097/00003086-199711000-00005 The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model 

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로